Cocrystal Pharma Inc (COCP)
1.73
-0.02
(-1.14%)
USD |
NASDAQ |
May 10, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
Cocrystal Pharma Cash from Financing (TTM): 3.993M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.993M |
September 30, 2023 | 3.986M |
June 30, 2023 | 3.979M |
March 31, 2023 | -0.028M |
December 31, 2022 | -0.027M |
September 30, 2022 | -0.029M |
June 30, 2022 | -0.033M |
March 31, 2022 | 36.40M |
December 31, 2021 | 38.47M |
September 30, 2021 | 42.09M |
June 30, 2021 | 57.64M |
March 31, 2021 | 21.18M |
December 31, 2020 | 35.66M |
September 30, 2020 | 34.71M |
June 30, 2020 | 19.12M |
March 31, 2020 | 19.10M |
December 31, 2019 | 6.424M |
September 30, 2019 | 3.793M |
June 30, 2019 | 3.835M |
March 31, 2019 | 11.58M |
December 31, 2018 | 8.893M |
September 30, 2018 | 9.869M |
June 30, 2018 | 9.949M |
March 31, 2018 | 5.264M |
December 31, 2017 | 4.08M |
Date | Value |
---|---|
September 30, 2017 | 3.08M |
June 30, 2017 | 7.009M |
March 31, 2017 | 4.009M |
December 31, 2016 | 9.016M |
September 30, 2016 | 9.019M |
June 30, 2016 | 5.01M |
March 31, 2016 | 9.06M |
December 31, 2015 | 15.88M |
September 30, 2015 | 15.88M |
June 30, 2015 | 15.94M |
March 31, 2015 | 11.93M |
December 31, 2014 | 2.866M |
September 30, 2014 | 2.867M |
June 30, 2014 | 2.809M |
March 31, 2014 | 2.772M |
December 31, 2013 | 0.007M |
September 30, 2013 | 0.0956M |
June 30, 2013 | -0.3547M |
March 31, 2013 | -0.1209M |
December 31, 2012 | 1.714M |
September 30, 2012 | 2.056M |
June 30, 2012 | 0.7868M |
March 31, 2012 | -0.0613M |
December 31, 2011 | 0.5755M |
September 30, 2011 | 0.1436M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.033M
Minimum
Jun 2022
57.64M
Maximum
Jun 2021
17.38M
Average
6.424M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |